A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus

por Kiruthika, S., Bhat, Ruchika, Dash, Rozaleen, Rathore, Anurag S., Vivekanandan, Perumal, Jayaram, B.
Publicado 2021